Villaronga, M.A.; López-Mateo, I.; Markert, L.; Espinosa, E.; Fresno Vara, J.A.; Belandia, B. "Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.". Breast Cancer Res. Treat.. 128(3): 891-898. (2011). (PMID: 21465167).
Lavery, D.N.; Villaronga, M.A.; Walker, M.M.; Patel, A.; Belandia, B.; Bevan, C.L. "Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.". J. Biol. Chem.. 286(20): 17796-17808. (2011). (PMID: 21454491).
Villaronga, M.A.; Bevan, C.L.; Belandia, B. "Notch signaling: a potential therapeutic target in prostate cancer.". Curr Cancer Drug Targets. 8(7): 566-580. (2008). (PMID: 18991567).
Kiskinis, E.; García-Pedrero, J.M.; Villaronga, M.A.; Parker, M.G.; Belandia, B. "Identification of BAF57 mutations in human breast cancer cell lines.". Breast Cancer Res. Treat.. 98(2): 191-198. (2006). (PMID: 16538531).
Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401 Email:Info